Cargando…

Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device

The aim of this study was to determine whether the Hem-Col method of obtaining and storing blood is an acceptable alternative to venepuncture for measuring Diabetes Care parameters. Design and methods: Hem-Col is a novel blood collection device that is designed to collect capillary blood drawn with...

Descripción completa

Detalles Bibliográficos
Autores principales: Huijskens, M.J.A.J., Castel, R., Vermeer, H.J., Verheijen, F.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804795/
https://www.ncbi.nlm.nih.gov/pubmed/31649987
http://dx.doi.org/10.1016/j.plabm.2019.e00135
_version_ 1783461270529245184
author Huijskens, M.J.A.J.
Castel, R.
Vermeer, H.J.
Verheijen, F.M.
author_facet Huijskens, M.J.A.J.
Castel, R.
Vermeer, H.J.
Verheijen, F.M.
author_sort Huijskens, M.J.A.J.
collection PubMed
description The aim of this study was to determine whether the Hem-Col method of obtaining and storing blood is an acceptable alternative to venepuncture for measuring Diabetes Care parameters. Design and methods: Hem-Col is a novel blood collection device that is designed to collect capillary blood drawn with a finger prick. Hem-Col is a microtube containing an anticoagulant and a preservation buffer to enhance analyte stability in whole blood. The Diabetes Care parameters cholesterol, creatinine, HbA1c, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, and triglycerides were measured both in blood/plasma collected via Hem-Col and blood/plasma collected with venepuncture. The results were compared to assess the agreement between the two methods. Results: HbA1c shows agreement after storage for up to 120 hours at temperatures ranging from 4 to 37 °C. Cholesterol, HDL cholesterol, LDL cholesterol, triglycerides and creatinine can be measured after 120 hours of storage in Hem-Col buffer, if high temperatures are avoided, and with the use of correction factors or adaptations to reported reference intervals. Conclusion: Hem-Col is suitable for the measurement of HbA1c after storage for up to 120 hours at temperatures ranging from 4 to 37 °C. Cholesterol, creatinine, HDL cholesterol, LDL cholesterol and triglycerides can be measured after 120 hours of storage in Hem-Col buffer, if high temperatures are avoided. Further studies are required to determine whether Hem-Col can replace the venepuncture for the Diabetes Care parameters.
format Online
Article
Text
id pubmed-6804795
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-68047952019-10-24 Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device Huijskens, M.J.A.J. Castel, R. Vermeer, H.J. Verheijen, F.M. Pract Lab Med Article The aim of this study was to determine whether the Hem-Col method of obtaining and storing blood is an acceptable alternative to venepuncture for measuring Diabetes Care parameters. Design and methods: Hem-Col is a novel blood collection device that is designed to collect capillary blood drawn with a finger prick. Hem-Col is a microtube containing an anticoagulant and a preservation buffer to enhance analyte stability in whole blood. The Diabetes Care parameters cholesterol, creatinine, HbA1c, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, and triglycerides were measured both in blood/plasma collected via Hem-Col and blood/plasma collected with venepuncture. The results were compared to assess the agreement between the two methods. Results: HbA1c shows agreement after storage for up to 120 hours at temperatures ranging from 4 to 37 °C. Cholesterol, HDL cholesterol, LDL cholesterol, triglycerides and creatinine can be measured after 120 hours of storage in Hem-Col buffer, if high temperatures are avoided, and with the use of correction factors or adaptations to reported reference intervals. Conclusion: Hem-Col is suitable for the measurement of HbA1c after storage for up to 120 hours at temperatures ranging from 4 to 37 °C. Cholesterol, creatinine, HDL cholesterol, LDL cholesterol and triglycerides can be measured after 120 hours of storage in Hem-Col buffer, if high temperatures are avoided. Further studies are required to determine whether Hem-Col can replace the venepuncture for the Diabetes Care parameters. Elsevier 2019-09-19 /pmc/articles/PMC6804795/ /pubmed/31649987 http://dx.doi.org/10.1016/j.plabm.2019.e00135 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Huijskens, M.J.A.J.
Castel, R.
Vermeer, H.J.
Verheijen, F.M.
Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device
title Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device
title_full Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device
title_fullStr Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device
title_full_unstemmed Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device
title_short Evaluation of Diabetes Care parameters in capillary blood collected with a novel sampling device
title_sort evaluation of diabetes care parameters in capillary blood collected with a novel sampling device
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804795/
https://www.ncbi.nlm.nih.gov/pubmed/31649987
http://dx.doi.org/10.1016/j.plabm.2019.e00135
work_keys_str_mv AT huijskensmjaj evaluationofdiabetescareparametersincapillarybloodcollectedwithanovelsamplingdevice
AT castelr evaluationofdiabetescareparametersincapillarybloodcollectedwithanovelsamplingdevice
AT vermeerhj evaluationofdiabetescareparametersincapillarybloodcollectedwithanovelsamplingdevice
AT verheijenfm evaluationofdiabetescareparametersincapillarybloodcollectedwithanovelsamplingdevice